Abinopharm Inc. Receives Award for NMN Human Clinical Trial Excellence

We are pleased to announce that our CEO, Lin Yi, received the third prize for the 2024 Outstanding Original Research Paper Award from the American Aging Association (AGE) at AGE’s 52nd Annual Meeting on June 3, 2024. The award recognized the research paper published in GeroScience on our NMN human clinical trial.